Patent holdings for IPC class A61K 31/39

Total number of patents in this class: 105

10-year publication summary

4
7
4
8
6
5
4
12
12
0
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Geistlich Pharma AG
166
7
Boehringer Ingelheim International GmbH
4748
5
CeNeRx Biopharma, Inc.
9
5
Enanta Pharmaceuticals, Inc.
427
4
Mydecine Innovations Group Inc.
34
4
The Procter & Gamble Company
22132
3
ArQule, Inc.
138
3
The Cleveland Clinic Foundation
1580
3
Metacrine, Inc.
33
3
Pierre Fabre Medicament
609
3
Cellusion Inc.
15
3
Nihon Nohyaku Co., Ltd.
315
2
Spectrum Pharmaceuticals, Inc.
86
2
The University of Tokyo
4073
2
Yeda Research and Development Co. Ltd.
1307
2
Allergan, Inc.
2432
1
Bayer Cropscience SA
51
1
The Johns Hopkins University
5543
1
University of South Florida
1835
1
Adamed Sp. z o.o.
23
1
Other owners 49